Remove topic nasdaq-inc
article thumbnail

How Governance Professionals Are Guiding Corporate Disclosure on E&S Topics

Harvard Corporate Governance

Posted by Sarah Crowe and Charles Neidenbach, Nasdaq, Inc., on Monday, August 7, 2023 Editor's Note: Sarah Crowe is ESG and Sustainability Channel Lead and Charles Neidenbach is a Lead ESG Advisor at Nasdaq. This post is based on a publication by Nasdaq ESG Solutions.

188
188
article thumbnail

Tiny US Online Betting Firm Rush Street Interactive Contacts DraftKings As It Seeks Strategic Options

Benzinga

Rush Street Interactive Inc (NYSE: RSI ), the Chicago-based online betting firm, is considering strategic options that could potentially lead to a sale. The exploration includes contacting potential buyers such as DraftKings Inc (NASDAQ: DKNG ).

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Diversity, Experience, and Effectiveness in Board Composition

Harvard Corporate Governance

Posted by Merel Spierings, The Conference Board, Inc., Related research from the Program on Corporate Governance includes Politics and Gender in the Executive Suite by Alma Cohen, Moshe Hazan, and David Weiss (discussed on the Forum here ); Will Nasdaq’s Diversity Rules Harm Investors? by Jesse M. Strine, Jr.

306
306
article thumbnail

Xbox's Head Phil Spencer On The Microsoft-Activision Deal: 'I'm Confident We'll Find Solutions'

Benzinga

Xbox head Phil Spencer said Microsoft Corp (NASDAQ: MSFT ) had an unwavering commitment to the anticipated acquisition of Activision Blizzard Inc (NASDAQ: ATVI ) and having confidence in its completion.

52
article thumbnail

Exclusive: Arbitrage Expert Julian Klymochko Breaks Down Twitter Acquisition And Elon Musk's Options

Benzinga

News of Tesla Inc (NASDAQ: TSLA ) CEO Elon Musk acquiring social media platform Twitter Inc (NYSE: TWTR ) has been one of the biggest topics of the investing world in 2022. Musk offered to buy Twitter shares for $54.20 each, yet shares have been trading around the $49 level.

97
article thumbnail

Weekly Roundup: August 4-10, 2023

Harvard Corporate Governance

CEO Tenure Rates Posted by Joyce Chen, Equilar Inc., Posted by the Harvard Law School Forum on Corporate Governance, on Friday, August 11, 2023 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of August 4-10, 2023.

article thumbnail

Why Harrow Health Stock Is Trading Higher Today?

Benzinga

Harrow Health Inc (NASDAQ: HROW ) agreed to acquire the U.S. Vevye, which is dispensed topically in a unique 10 microliter per one drop and is labeled for twice‑daily (BID) dosing, is the first and only cyclosporine-based product indicated for signs and symptoms of dry eye disease (DED). Deal terms were not disclosed.